MTP - Midatech Pharma Plc

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
-0.0300 (-2.7523%)
As of 10:54AM EST. Market open.
Stock chart is not supported by your current browser
Previous Close1.0900
Bid1.0800 x 300
Ask1.1000 x 200
Day's Range1.0600 - 1.0958
52 Week Range1.0000 - 3.6500
Avg. Volume8,032
Market Cap33.326M
PE Ratio (TTM)N/A
EPS (TTM)-1.2860
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Zacks Small Cap Research18 days ago

    Initiating Coverage of Midatech Pharma (MTP); Novel Nanotechnology Platforms Focused on Oncology and Other Therapeutic Areas

    We are initiating coverage of Midatech Pharma Plc (NASDAQ:PLC) with a $6.00 valuation. MIdatech is a U.K. based international specialty pharmaceutical company focused on oncology and other therapeutic areas. The company has three proprietary drug delivery technologies: Q-Sphera for sustained release of already marketed products, Midacore gold nanoparticles (GNP) for targeted delivery, and Nano Inclusion (NI) for local delivery.

  • Is Midatech Pharma Plc (AIM:MTPH) Undervalued?
    Simply Wall St.2 months ago

    Is Midatech Pharma Plc (AIM:MTPH) Undervalued?

    Midatech Pharma Plc (AIM:MTPH), a biotechnology company based in United Kingdom, saw significant share price volatility over the past couple of months on the AIM, rising to the highs ofRead More...

  • We're sorry this is all we were able to find about this topic.